Yunchao Su

Professor

Yunchao Su

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Pharmacology and Toxicology

Medical College of Georgia
Department of Medicine: Pulmonary

The Graduate School

Bio

Dr. Yunchao Su received his M.D. degree in 1985 and a Ph.D. in Pathophysiology in 1991 from the Tongji Medical College, Huazhong University of Science and Technology in China. He completed postdoctoral training at the Wellcome Pharmaceutical Research Laboratories in UK where he studied under Dr. Salvador Moncada and in the Department of Medicine at the University of Florida in USA where he worked with Dr. Edward R. Block. Dr. Su joined the faculty as an Assistant Professor in 1999 and became an Associate Professor in 2005 in the Department of Medicine at the University of Florida in USA. Currently, he is a tenured Professor in the Department of Pharmacology and Toxicology at the Medical College of Georgia of Augusta University, Augusta, GA, USA.

  • (706) 721-7641
  • (706) 721-2347
  • CB 3524

Education

  • Ph.D., Pathology Residency Program Tongji Medical University, 1991

  • MMSC, Pathology Residency Program Tongji Medical University, 1988

  • MD, Medicine Tongji Medical University, 1985

Courses Taught Most Recent Academic Year

  • MEDI 6320

    Brain, Behavior, & Movement
  • PHRM 9020

    Seminar in Pharmacology

Teaching Interests

Immune Pharmacology, Anticoagulants and Thrombolytics, Drug Discovery, Respiratory Pharmacology, Cardiovascular Pharmacology

Scholarship

Selected Recent Publications

  • Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction, 2022
    Journal Article, Academic Journal
  • Pleural mesothelial cell migration into lung parenchyma by calpain contributes to idiopathic pulmonary fibrosis, 2022
    Journal Article, Academic Journal
  • HDAC6 Activates ERK in Airway and Pulmonary Vascular Remodeling of Chronic Obstructive Pulmonary Disease, 2021
    Journal Article, Academic Journal
  • Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia, 2021
    Journal Article, Academic Journal
  • Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin‐induced acute lung injury, 2021
    Journal Article, Academic Journal

Research Interests

1. Cellular and molecular mechanisms of pulmonary circulation. 2. Airway and pulmonary vascular remodeling in COPD. 3. Lung injury and repair/fibrosis in tobacco smoke exposure.